cGMP peptide development and synthesis is the core of our business. AmbioPharm provides large-scale cGMP peptide services with capacity up to 400 kilograms per project. Our comprehensive experience and capacity for cGMP-grade synthesis of new chemical entities (NCEs) or generic peptides (G-Rx) unique in our industry. We partner from early preclinical studies through clinical evaluations and final commercial production.
Interested in learning more about Peptide Services? Contact Us.